Is HIV Infection a Risk Factor for Multi-Drug Resistant Tuberculosis? A Systematic Review

Background Tuberculosis (TB) is an important cause of human suffering and death. Human immunodeficiency virus (HIV), multi-drug resistant TB (MDR-TB), and extensive drug resistant tuberculosis (XDR-TB) have emerged as threats to TB control. The association between MDR-TB and HIV infection has not yet been fully investigated. We conducted a systematic review and meta-analysis to summarize the evidence on the association between HIV infection and MDR-TB. Methods and Results Original studies providing Mycobacterium tuberculosis resistance data stratified by HIV status were identified using MEDLINE and ISI Web of Science. Crude MDR-TB prevalence ratios were calculated and analyzed by type of TB (primary or acquired), region and study period. Heterogeneity across studies was assessed, and pooled prevalence ratios were generated if appropriate. No clear association was found between MDR-TB and HIV infection across time and geographic locations. MDR-TB prevalence ratios in the 32 eligible studies, comparing MDR-TB prevalence by HIV status, ranged from 0.21 to 41.45. Assessment by geographical region or study period did not reveal noticeable patterns. The summary prevalence ratios for acquired and primary MDR-TB were 1.17 (95% CI 0.86, 1.6) and 2.72 (95% CI 2.03, 3.66), respectively. Studies eligible for review were few considering the size of the epidemics. Most studies were not adjusted for confounders and the heterogeneity across studies precluded the calculation of a meaningful overall summary measure. Conclusions We could not demonstrate an overall association between MDR-TB and HIV or acquired MDR-TB and HIV, but our results suggest that HIV infection is associated with primary MDR-TB. Future well-designed studies and surveillance in all regions of the world are needed to better clarify the relationship between HIV infection and MDR-TB.

[1]  S. A. Abdool Karim,et al.  A retrospective study of human immunodeficiency virus infection and drug-resistant tuberculosis in Durban, South Africa. , 1997, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[2]  D. Wilkinson Anti-tuberculosis drug resistance in the world: The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Geneva: World Health Organization, 1997. 228pp. Price Sw. fr 25/US$22.50 (in developing countries Sw. fir 17.50). (Reference WHO/TB/97.229) , 1998 .

[3]  F. Cobelens,et al.  Drug resistance among smear-positive tuberculosis patients in Ho Chi Minh City, Vietnam. , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[4]  G. Ippolito,et al.  Drug resistance patterns among tuberculosis patients in Rome, 1990-1992. , 1996, Scandinavian journal of infectious diseases.

[5]  T. Frieden,et al.  The emergence of drug-resistant tuberculosis in New York City. , 1993, The New England journal of medicine.

[6]  K. D. de Cock,et al.  HIV infection and primary resistance to antituberculosis drugs in Abidjan, Côte d'Ivoire , 1992, AIDS (London).

[7]  Brian G. Williams,et al.  Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis , 2002, Science.

[8]  R. O'brien,et al.  Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. , 2008, American journal of respiratory and critical care medicine.

[9]  H. Crowe,et al.  Drug malabsorption and resistant tuberculosis in HIV-infected patients. , 1995, The New England journal of medicine.

[10]  J. Cohn HIV-1 infection in injection drug users. , 2002, Infectious disease clinics of North America.

[11]  F. Drobniewski,et al.  Antibiotic resistant tuberculosis in the United Kingdom: 1993–1999 , 2002, Thorax.

[12]  L. P. Ormerod Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment. , 2005, British medical bulletin.

[13]  A. R. Escombe,et al.  Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru. , 2006, The American journal of tropical medicine and hygiene.

[14]  K. Holmes,et al.  Multidrug-resistant Mycobacterium tuberculosis in HIV-Infected Persons, Peru , 2003, Emerging infectious diseases.

[15]  F. Drobniewski,et al.  A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UK , 2002, Thorax.

[16]  J. T. Crawford,et al.  A CONTINUING SURVEY OF DRUG-RESISTANT TUBERCULOSIS , 1997 .

[17]  M. Mwasekaga,et al.  Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[18]  E. Waldman,et al.  A population-based study of drug resistance and transmission of tuberculosis in an urban community. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[19]  F. Drobniewski,et al.  Explaining risk factors for drug-resistant tuberculosis in England and Wales: contribution of primary and secondary drug resistance , 2004, Epidemiology and Infection.

[20]  Christopher Dye,et al.  Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. , 2001, The New England journal of medicine.

[21]  M. F. Pereira,et al.  Anti-tuberculosis drug resistance in Portugal. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[22]  R. O'brien,et al.  An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991–1993 , 1996, AIDS.

[23]  J. Robert,et al.  Surveillance of Mycobacterium tuberculosis drug resistance in France, 1995-1997. AZAY Mycobacteria Study Group. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[24]  Neel R Gandhi,et al.  Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa , 2006, The Lancet.

[25]  T. Holtz,et al.  HIV infection and multidrug-resistant tuberculosis: the perfect storm. , 2007, The Journal of infectious diseases.

[26]  A. Laszlo,et al.  Anti-tuberculosis drug resistance in the world. Fourth global report. The WHO / IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance 2002-2007. , 2003 .

[27]  C. Gilham,et al.  Database study of antibiotic resistant tuberculosis in the United Kingdom, 1994-6 , 1999, BMJ.

[28]  R. Wood,et al.  HIV infection is not associated with an increased rate of drug-resistant tuberculosis. , 1997, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[29]  Diane Brown The emergence of drug-resistant tuberculosis in New York City , 1993 .

[30]  A. R. L. Campelo,et al.  Characteristics of pulmonary tuberculosis in HIV seropositive and seronegative patients in a Northeastern region of Brazil. , 2004, Revista da Sociedade Brasileira de Medicina Tropical.

[31]  P. Sonnenberg,et al.  Drug-resistant pulmonary tuberculosis in a cohort of southern African goldminers with a high prevalence of HIV infection. , 2000, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[32]  J. Grosset,et al.  Multidrug resistant tuberculosis in France 1992-4: two case-control studies , 1998, BMJ.

[33]  D. Hom,et al.  Accelerated course of human immunodeficiency virus infection after tuberculosis. , 1995, American journal of respiratory and critical care medicine.

[34]  I. Onorato,et al.  Cross-matching TB and AIDS registries: TB patients with HIV co-infection, United States, 1993-1994. , 1999, Public health reports.

[35]  J. Sacarlal,et al.  Characteristics of drug resistance and HIV among tuberculosis patients in Mozambique. , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[36]  S. Lawn,et al.  Immune reconstitution and "unmasking" of tuberculosis during antiretroviral therapy. , 2008, American journal of respiratory and critical care medicine.

[37]  H L Rieder,et al.  Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. , 2001, The New England journal of medicine.

[38]  W. El-Sadr,et al.  The impact of human immunodeficiency virus infection on drug-resistant tuberculosis. , 1996, American journal of respiratory and critical care medicine.

[39]  C. Rodrigo,et al.  Prospective study of drug-resistant tuberculosis in a spanish urban population including patients at risk for HIV infection , 1995, European Journal of Clinical Microbiology and Infectious Diseases.

[40]  J. Taylor,et al.  Epidemiology of drug-resistant tuberculosis in Texas. , 1999, American journal of epidemiology.

[41]  Christopher Dye,et al.  The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. , 2003, Archives of internal medicine.

[42]  C. Woodley,et al.  Multidrug-resistant tuberculosis in the New York State prison system, 1990-1991. , 1994, The Journal of infectious diseases.

[43]  L. Finelli,et al.  Epidemiology of drug-resistant tuberculosis in New Jersey from 1991 to 1995. , 1998, International journal of epidemiology.

[44]  P. Della‐Latta,et al.  Drug-resistant tuberculosis in Castilla-León, Spain, 1996-2000. , 2006, The International Journal of Tuberculosis and Lung Disease.

[45]  D. Haas,et al.  Multidrug-resistant tuberculosis at an HIV testing center in Haiti , 2006, AIDS.

[46]  H. Yanai,et al.  Prevalence of drug-resistant tuberculosis in an HIV endemic area in northern Thailand. , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[47]  G. Marchal,et al.  Tuberculosis in HIV-infected patients: a comprehensive review. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[48]  R. Coker,et al.  Review: Multidrug‐resistant tuberculosis: public health challenges , 2004, Tropical medicine & international health : TM & IH.

[49]  N. Shaffer,et al.  Human immunodeficiency virus-related tuberculosis and primary drug resistance in Bangkok, Thailand. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[50]  A. Faustini,et al.  Risk factors for multidrug resistant tuberculosis in Europe: a systematic review , 2005, Thorax.

[51]  Lung Disease,et al.  Anti-tuberculosis drug resistance in the world : the WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance , 1997 .

[52]  D. Ridley,et al.  Cape Town, South Africa , 1986, Journal of clinical ultrasound : JCU.

[53]  J. T. Crawford,et al.  A continuing survey of drug-resistant tuberculosis, New York City, April 1994. , 1997, Archives of internal medicine.

[54]  S. Mehendale,et al.  Drug resistance pattern of Mycobacterium tuberculosis in seropositive and seronegative HIV-TB patients in Pune, India. , 2005, The Indian journal of medical research.

[55]  K. Castro,et al.  Trends in drug-resistant tuberculosis in the United States, 1993-1996. , 1997, JAMA.